INTERNATIONAL PATENT: BLUEROCK THERAPEUTICS LP FILES APPLICATION FOR "GENETICALLY MODIFIED CELLS FOR ENHANCED IMMUNE EVASION IN ALLOGENEIC CELLULAR THERAPIES"

GENEVA, May 28 -- BLUEROCK THERAPEUTICS LP (238 Main Street, 3rd FloorCambridge, MA 02142) filed a patent application (PCT/US2024/055753) for "GENETICALLY MODIFIED CELLS FOR ENHANCED IMMUNE EVASION IN ALLOGENEIC CELLULAR THERAPIES" on Nov 13, 2024. With publication no. WO/2025/106557, the details related to the patent application was published on May 22, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): MILASTA, Sandra (238 Main Street, 3rd FloorCambridge, MA 02142), GOMEZ-ARISTIZABAL, Alejandro (238 Main Street, 3rd FloorCambridge, MA 02142), HENDRIKS, Wilhelmus, Theodorus (238 Main Street, 3...